Life science and nutraceutical company Fytexia has announced its investment in B Natural, a company that specialises in brown propolis.
Made by bees, propolis is a source of polyphenols with several health benefits, including antimicrobial, anti-fungal, anti-viral and anti-inflammatory.
After looking to make an investment in a source of propolis, Fytexia opted for Italian B Natural, impressed by the company’s sourcing, quality of materials, standardisation and patented extraction method which ensures unique batch-to-batch uniformity and ease of production.
Fytexia’s investment in B Natural will help the Italian company’s growth and development of new propolis products.
Matthieu Arguillère, CEO of Fytexia, commented: “We are very excited by this investment, and we believe that it will open up new growth opportunities. There are major opportunities for synergies between Fytexia and B Natural, some of them immediately applicable. This partnership will allow Fytexia and B Natural to create a strong European leader in polyphenols.”
Gianluca Imbriani, CEO of B Natural, added: “Making a traditional material such as propolis into a very premium ingredient is very exciting. We worked a lot over the past years securing sourcing and ensuring the quality and standardization of our propolis product. We believe that together with Fytexia we will be able to accelerate the development of propolis and its scientifically proven health benefits.
“We share a common vision and our partnership should help in the development of health uses for a range of other polyphenols as well.“